股票 › BAX
Baxter International 公司 BAX
美股市值排名 #1229
$25.79 +$0.14 (+0.55%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $25.69 -0.39%
开盘$24.99
昨收$25.65
当日区间$24.76 – $25.83
成交量6.20M
市值$13.34B
市盈率（TTM）–
股息率0.16%
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例109.2%-0.52 个百分点，较上季度
持仓机构数843+23 ，较上季度
内部人近期交易24次买入 / 16次卖出净买入
空头持仓比例4.60% 占流通股回补天数 4.2 · 截至 15 Oct 2026
卖空成交量占比24.8%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$52.79M（6个净流入日，14个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有53.0%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从6.32%降至4.60%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| WEDGE Capital Management LLP | Mutual Fund | 2026/Q3 | +1,065,501 | 0.2% |
| Citigroup Inc. | Public Company | 2026/Q3 | +595,821 | 0.2% |
| Aegon Asset Management UK Plc | Mutual Fund | 2026/Q3 | +534,356 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +545,166 | 0.1% |
| Strategic Advisers LLC | Mutual Fund | 2026/Q3 | +5,140,585 | 3.7% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +4,954,205 | 2.1% |
| Holocene Advisors, LP | Hedge Fund | 2026/Q3 | +2,666,396 | 0.5% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +2,590,559 | 0.9% |
| FMR | Mutual Fund | 2026/Q3 | +2,508,442 | 6.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,441,441 | 15.8% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +1,695,646 | 0.4% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +1,585,261 | 0.9% |
| Defilade Capital Management, L.P. | Hedge Fund | 2026/Q3 | +1,459,380 | 0.3% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +1,387,609 | 0.4% |
| Dodge & Cox | Mutual Fund | 2026/Q3 | +1,131,775 | 11.3% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 30 Sep 2026 | John Rogers | Chief Financial Officer | Initial Statement of Beneficial | +0 | – | – |
| 14 Sep 2026 | Bernie Heine | Interim Chief Accounting Officer & Controller | Initial Statement of Beneficial | +0 | – | 32,840 |
| 1 Sep 2026 | Andrew Hider | CEO, Pres., Interim Group Pres. of Medical Products & Therapies and Director | Sale to Issuer | -54,276 | $25.70 | 71,276 |
| 1 Sep 2026 | Julie Foster | President of Front Line Care | Sale to Issuer | -2,098 | $25.70 | 29,164 |
| 31 Aug 2026 | James Teaff | President of Care & Connectivity Solutions | Sale to Issuer | -750 | $25.48 | 30,370 |
| 1 Jun 2026 | Steven Wallace | President of Advanced Surgery & Commercial Excellence | Sale to Issuer | -153 | $18.68 | 70,128 |
| 1 Jun 2026 | James Teaff | President of Care & Connectivity Solutions | Sale to Issuer | -321 | $18.68 | 31,063 |
| 31 May 2026 | Anita Zielinski | Former Interim CFO, Senior VP, Chief Accounting Officer & Controller | Other Acquisition | +13,426 | – | 55,705 |
| 4 May 2026 | Michael McDonnell | Independent Director | Other Acquisition | +12,836 | – | 14,647 |
| 4 May 2026 | Amy McBride-Wendell | Independent Director | Other Acquisition | +12,836 | – | 44,235 |
| 4 May 2026 | Patricia Morrison | Independent Director | Other Acquisition | +12,836 | – | 42,386 |
| 4 May 2026 | Nancy Schlichting | Independent Director | Other Acquisition | +12,836 | – | 34,994 |
| 4 May 2026 | David Shafer | Independent Chairperson | Other Acquisition | +12,836 | – | 72,804 |
| 4 May 2026 | Jeffrey Craig | Independent Director | Other Acquisition | +12,836 | – | 23,662 |
| 4 May 2026 | David Wilkes | Independent Director | Other Acquisition | +12,836 | – | 37,076 |
| 4 May 2026 | William Ampofo | Independent Director | Other Acquisition | +12,836 | – | 30,375 |
| 31 Mar 2026 | Steven Wallace | President of Advanced Surgery & Commercial Excellence | Initial Statement of Beneficial | +0 | – | 67,972 |
| 31 Mar 2026 | Julie Foster | President of Front Line Care | Initial Statement of Beneficial | +0 | – | 25,862 |
| 31 Mar 2026 | James Teaff | President of Care & Connectivity Solutions | Initial Statement of Beneficial | +0 | – | 55,119 |
| 5 Mar 2026 | Joel Grade | Former Chief Financial Officer | Sale to Issuer | -8,153 | $17.69 | 74,520 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 23,765,665 | 4.6% | 4.2 |
| 30 Sep 2026 | 24,366,869 | 4.7% | 3.0 |
| 15 Sep 2026 | 23,227,313 | 4.5% | 4.5 |
| 31 Aug 2026 | 23,293,667 | 4.5% | 5.0 |
| 14 Aug 2026 | 23,914,369 | 4.6% | 3.0 |
| 31 Jul 2026 | 32,667,256 | 6.3% | 4.3 |
暂无评论——快来第一个聊聊 BAX。
登录后参与讨论。